Putnam Investments’s Ginkgo Bioworks DNA Stock Holding History

Putnam Investments’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.54M	Buy	37,560 +1,021	+3%	+$62.5K	﹤0.01%	702
2023 Q3	$2.65M	Buy	36,539 +1,290	+4%	+$103K	﹤0.01%	666
2023 Q2	$2.62M	Sell	35,249 -44,793	-56%	-$2.65M	﹤0.01%	687
2023 Q1	$4.26M	Buy	80,042 +17,328	+28%	+$1.1M	0.01%	473
2022 Q4	$4.24M	Buy	62,714 +18,868	+43%	+$1.74M	0.01%	480
2022 Q3	$5.47M	Buy	43,846 +26,694	+156%	+$3.18M	0.01%	405
2022 Q2	$1.63M	Buy	17,152 +253	+1%	+$30.9K	﹤0.01%	791
2022 Q1	$2.72M	Sell	16,899 -2,812	-14%	-$547K	﹤0.01%	739
2021 Q4	$6.55M	Sell	19,711 -21,460	-52%	-$10.2M	0.01%	472
2021 Q3	$19.1M	Buy	+41,171	New	+$20M	0.03%	249

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments's DNA Position: Q4 2023 in Review

Putnam Investments increased its Ginkgo Bioworks (DNA) stake by 2.8% in Q4 2023, buying an estimated $62.5K and bringing the position to 37,560 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Putnam Investments first reported a position in DNA in Q3 2021 and has held it in 10 quarters since. The position peaked at $19.1M in Q3 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

Putnam Investments held 37,560 shares of Ginkgo Bioworks worth $2.54M as of Q4 2023.
Putnam Investments bought 1,021 Ginkgo Bioworks shares in Q4 2023, an estimated $62.5K.
Ginkgo Bioworks made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #702 holding.
Putnam Investments first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 10 quarters since.
Putnam Investments's Ginkgo Bioworks position peaked at $19.1M in Q3 2021.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.